Questions to Ask Your Team Before Pheochromocytoma Surgery: Genetics, Timing and the Plan

The scan report uses a word most people have never heard, and the surgeon says the operation is not the hard part. The hard part, she explains, is the two weeks before it. That is a strange thing to hear when you have just been told you have a tumor on an adrenal gland, and it is exactly why the right questions before pheochromocytoma surgery matter so much.

A pheochromocytoma is a rare, usually noncancerous tumor of the adrenal medulla, the inner part of the small gland that sits on top of each kidney. It makes catecholamines, the stress hormones adrenaline and noradrenaline, in unpredictable bursts. Removing it fixes the source. Handling it safely on the way out is a team sport involving an endocrinologist, an anesthesiologist, a surgeon and often a genetic counselor.

This explainer walks through what those people will want to discuss with you, and what you should ask back.

What actually happens during pheochromocytoma surgery?

The operation is an adrenalectomy, which simply means removal of the adrenal gland, or occasionally only the tumor-bearing part of it. For most adrenal pheochromocytomas, published guidance favors a minimally invasive approach: a few small incisions, a camera and long instruments, with the surgeon working either from the front of the abdomen or from the back. Larger tumors, tumors that look invasive on imaging, and some tumors outside the adrenal gland (called paragangliomas) are more often removed through an open incision so the surgeon can control bleeding and avoid rupturing the capsule.

What makes this surgery different from almost any other is what the tumor does when touched. Pressing, pulling or cutting near it can squeeze out a surge of catecholamines, and blood pressure can climb steeply within seconds. Once the vein draining the tumor is clipped, the opposite problem arrives: hormone levels fall abruptly, blood vessels relax, and pressure can drop just as fast.

So the anesthesia team works like a pilot in crosswinds. An arterial line gives a beat-to-beat blood pressure reading. Short-acting intravenous medicines are kept ready to push pressure down during handling and to support it after the gland is out. The surgeon tries to isolate the adrenal vein early and handle the tumor as little as possible. The Endocrine Society’s clinical practice guideline on pheochromocytoma and paraganglioma describes this sequence, and notes that patients should be monitored closely afterward for low blood pressure and low blood sugar, both of which are predictable consequences of the hormone switching off.

Tissue goes to pathology. Because no single microscope feature reliably separates benign from malignant pheochromocytoma, the report usually describes risk features rather than giving a verdict, which is one reason follow-up continues for years.

Why alpha blockade before pheochromocytoma surgery matters more than the operation itself

Here is the sentence that surgeon was trying to get across: the medicine phase is the safety phase. Guideline authors recommend that every patient with a hormone-producing pheochromocytoma receive preoperative preparation, and the first step is almost always an alpha-adrenergic blocker, a class of drugs that stops adrenaline and noradrenaline from tightening blood vessels. With those receptors blocked, a mid-surgery hormone surge has far less to act on.

The mechanism explains the timeline. Catecholamines keep your vessels clamped down for months, so your circulating blood volume quietly shrinks to fit the narrowed pipes. When an alpha-blocker opens them, the volume has to catch up, or you will feel faint standing up. The Endocrine Society guideline suggests starting alpha blockade roughly 7 to 14 days before surgery, paired with a high-salt diet and generous fluid intake, precisely to allow that refill. Your team will adjust the medicine upward over those days according to your blood pressure readings lying and standing; those adjustments are theirs to make, not yours.

Beta-blockers, which slow the heart, often follow once alpha blockade is established, to control the fast heart rate that alpha-blockers can unmask. Order matters here. A beta-blocker given first, with alpha receptors still open, can leave blood vessels clamped with nothing to oppose them, and blood pressure may rise dangerously. This is the single most repeated warning in training material on the condition, and it is worth hearing from your own team so you understand why they sequence things as they do.

Some centers use calcium channel blockers, another class that relaxes vessel walls, either in addition or as an alternative in people who cannot tolerate alpha-blockers. Ask which strategy your team uses and what readings tell them you are ready for the operating room.

How should I prepare for pheochromocytoma surgery at home?

Most of the preparation happens in your own kitchen and hallway rather than in a hospital bed. Three habits do the heavy lifting.

Salt and fluid come first. Because the alpha-blocker expands your blood vessels, your body needs extra sodium and water to fill them. Teams commonly ask patients to eat liberally salted food and drink more than usual during the preparation period; the guideline frames this as part of volume expansion, and some patients receive intravenous saline the night before surgery as well. If you have heart or kidney disease, the plan will be individualized, so ask rather than assume.

Blood pressure checks at home come second. A validated upper-arm cuff, readings taken seated and then after standing for a minute, logged twice a day, give your prescriber the data they need to adjust medicines. Lightheadedness on standing is expected to a degree; a fall is not, so rise slowly and sit down if the room tilts.

Avoiding triggers is third. Anything that provokes a catecholamine release should be on hold until after surgery: strenuous straining, deep abdominal massage, and certain over-the-counter products. Decongestants and some stimulant medicines can provoke surges, and a handful of prescription classes, including certain antidepressants and some anesthetic and anti-nausea agents, are flagged in guidance as risky. Bring every bottle and supplement to your pre-op visit; the anesthesiologist will want the full list.

Practical details fill the rest. Confirm which medicines to take on the morning of surgery, what time to stop eating and drinking, and who will drive you home. Pack loose clothing: incision sites, even small ones, are tender. And ask whether a glucose check is planned afterward, since low blood sugar in the first hours is a known effect of the hormone source being removed.

Who is usually offered surgery now, and who is asked to wait

Surgery is the standard treatment for a pheochromocytoma that is producing hormones, because no medicine removes the source and the tumor can grow. Within that broad rule, timing is deliberately flexible, and “wait” rarely means “never.”

People are generally scheduled once two things are true: the diagnosis is biochemically confirmed, usually with blood or urine tests for metanephrines, the breakdown products of adrenaline that tumors release steadily; and preparation has brought blood pressure and heart rate into the target range the team has set. If either box is not ticked, the operation is postponed, not cancelled.

Several situations commonly push the date out. A tumor found by chance on a scan done for another reason, called an incidentaloma, needs hormone testing before anyone operates, because the surgical risk is entirely different if the mass is hormonally silent. Severe uncontrolled hypertension or a recent catecholamine-induced heart problem calls for a longer medical run-up. Pregnancy is a special case: guidance describes removing the tumor in the second trimester when possible, or managing it medically until delivery, and that decision involves obstetric and endocrine specialists together.

Genetic results can also change the sequence. In someone with a known hereditary syndrome, the team may want imaging of the other adrenal gland and of the neck, chest and pelvis before choosing an approach, since multiple tumors are more likely.

At the other end, a small group of patients are advised against surgery altogether, for example those whose other health conditions make anesthesia unsafe, or those with widespread metastatic disease where removing one tumor would not change the course. For them, long-term alpha blockade, targeted radiotherapy or other systemic treatments may be discussed. These are individualized judgments, and the right question is simply: “Which path are you recommending for me, and what would change your mind?”

What is the 10% rule for pheochromocytoma, and is it still true?

Generations of medical students learned the “rule of tens”: about 10% of pheochromocytomas are bilateral, 10% occur outside the adrenal gland, 10% are malignant, 10% are familial, and 10% occur in children. It is a tidy mnemonic. It is also out of date in the part that matters most to you.

The familial figure has been overturned by modern genetic testing. The Endocrine Society guideline, drawing on sequencing studies, reports that roughly one in three patients with pheochromocytoma or paraganglioma carries a germline mutation, meaning an inherited change present in every cell. That is three to four times the old estimate, and it is the reason the guideline recommends that all patients be offered genetic testing, not just those with a family history or a young age at diagnosis.

The extra-adrenal figure is also higher once paragangliomas of the head, neck, chest and pelvis are counted together. And the “10% malignant” figure is slippery because malignancy in this tumor is defined by spread to places where chromaffin tissue does not normally exist, not by how the cells look, so it can only be declared in hindsight.

Why should a patient care about a teaching mnemonic? Because if your team still frames your case with the old numbers, you may not be offered testing that could change the operation. A germline mutation raises the odds of a second tumor on the other side, which argues for a cortical-sparing technique that leaves some normal gland behind. It also changes how often you will be screened afterward, and whether your relatives should be tested.

So when you hear the rule of tens, treat it as a prompt, not a reassurance, and ask the follow-up question in the next section.

Pheochromocytoma genetic testing: the questions before pheochromocytoma surgery that change the plan

The most consequential question you can ask is: “Will I have genetic testing, and will the result be back before my operation?” Here is what sits behind it.

Several inherited syndromes include pheochromocytoma. Von Hippel-Lindau disease, multiple endocrine neoplasia type 2 (MEN2), neurofibromatosis type 1 and the group of succinate dehydrogenase (SDH) gene conditions are the best known. Each carries a different pattern: VHL and MEN2 tumors tend to be adrenal and frequently bilateral; SDHB-related tumors are more often outside the adrenal and more likely to spread. Those patterns are why the guideline recommends choosing which genes to test based on tumor location, hormone profile and family history, and why a genetic counselor is often part of the pre-op team.

A positive result can reshape the surgery in three ways. First, approach: in a hereditary syndrome with bilateral disease, surgeons may offer an adrenal-sparing operation to avoid lifelong steroid dependence, trading a small chance of recurrence for an intact cortex. Second, extent of imaging: additional scans may be ordered to look for tumors elsewhere before the first incision. Third, sequence: in MEN2, the thyroid also needs attention, and the pheochromocytoma is removed first because operating on the neck with an untreated adrenal tumor is hazardous.

Results are not always back in time, and that is acceptable; the operation does not usually wait on sequencing. What matters is that the sample is taken and the result shapes follow-up and family screening. Ask who will explain the result, whether your children or siblings should be tested, and how the finding affects the schedule of scans and metanephrine checks for years ahead. A negative test does not end surveillance; the guideline still recommends lifelong annual biochemical follow-up for everyone after removal, with closer attention for anyone with a mutation, a large tumor or a paraganglioma.

How soon should the operation happen, and what decides the timing?

Patients often arrive expecting urgency. The scan is alarming, the symptoms have been frightening, and surely the tumor should come out this week. In practice, the safe answer is usually “soon, but not yet.”

The clock is set by preparation rather than by the tumor. Most pheochromocytomas grow slowly, and the immediate danger is the hormone, which the medicines address within days. The 7-to-14-day window the guideline suggests for alpha blockade is a floor, not a ceiling; some patients with severe hypertension or heart strain need longer. Rushing to the operating room before blood pressure is controlled is the scenario the whole preparation protocol exists to prevent.

A few things can shorten or lengthen the plan. A catecholamine crisis, meaning a dangerous blood pressure spike with organ effects, is managed in hospital with intravenous medicines; the surgery still usually waits until the patient is stable. A very large or symptomatic tumor may be scheduled toward the earlier end of the range. Pregnancy, as noted, has its own calendar. And if you take a medicine that interferes with the hormone tests, your team may pause it under supervision and repeat the test before finalizing a date; that is their call, never one to make at home.

Ask these timing questions directly: What readings tell you I am ready? If I feel dizzy on the medicines, does that mean we are on track or that something is wrong? Who do I call if a reading is far outside the usual range at home? Will I be admitted a day early for intravenous fluids? And, importantly: if something delays the date, does my medicine plan continue unchanged until a new date is set?

A clear answer to each of those is a sign of a team that has done this before, which, given how rare the tumor is, is exactly what you want.

Surgical approaches compared: what to ask about the operation itself

Three decisions shape the operation: the route in, how much gland comes out, and how the surgeon handles the tumor. The table summarizes the trade-offs as guidelines describe them; your team weighs them against your anatomy, tumor size and genetic result.

Approach	Typically considered for	Main advantages	Main trade-offs
Laparoscopic (through the abdomen)	Most adrenal pheochromocytomas without signs of invasion	Small incisions, less pain, shorter hospital stay	Not suited to very large or invasive tumors
Retroperitoneoscopic (through the back)	Smaller tumors; bilateral cases; prior abdominal surgery	Avoids the abdominal cavity; direct path to the gland	Limited working space; surgeon experience matters
Open adrenalectomy	Large tumors, suspected malignancy, many paragangliomas	Full control of vessels; intact removal of large masses	Larger incision, longer recovery
Cortical-sparing (partial)	Hereditary bilateral disease, or a single remaining gland	May preserve enough cortex to avoid lifelong steroid replacement	Small chance tumor tissue is left and recurs

Two questions follow naturally. “If you start laparoscopically, what would make you convert to open?” is a fair thing to ask; conversion is a safety decision, not a failure. And “Will you remove the whole gland or spare part of it?” should be answered with reference to your genetic status and the health of your other adrenal gland. Removing both glands completely means lifelong cortisol and aldosterone replacement, which is manageable but not trivial, and sparing techniques exist precisely to avoid it where the risk balance allows.

Ask, too, about handling: whether the surgeon aims to clip the adrenal vein early, and how the tumor will be bagged for removal to avoid rupture. These details signal familiarity with the specific hazards of this tumor.

How risky is pheochromocytoma surgery, honestly?

The honest framing is that this is high-stakes surgery made much safer by preparation. Historical series from before routine alpha blockade and modern anesthesia reported substantial perioperative mortality; guideline authors note that with current protocols, serious complications have become uncommon. That sentence should not be read as a promise. It means the risk is real and that the protocol is what controls it.

The specific risks fall into three groups.

Hemodynamic risks are the signature ones. Blood pressure surges during tumor handling can, in rare cases, strain the heart or cause bleeding in the brain; anesthesia teams prepare for them with continuous monitoring and rapid-acting intravenous medicines. After the tumor’s vein is clipped, pressure can fall steeply, and some patients need intravenous fluids or vessel-tightening medicines for hours. Heart rhythm disturbances can occur in either phase.

Surgical risks are those of any adrenalectomy: bleeding from the adrenal or nearby vessels, injury to adjacent organs such as the spleen, pancreas, liver or kidney, infection, and the small chance of conversion from keyhole to open surgery. Tumor rupture is a specific concern because spilled cells can seed the abdomen.

Metabolic risks arrive after the operation. Catecholamines suppress insulin, so when they vanish, insulin release can rebound and blood sugar can drop; the guideline specifically advises monitoring for this. If both glands are removed, or if one was removed earlier, adrenal insufficiency follows and must be treated with replacement hormones from the first day.

Risk also depends on you. Age, heart function, kidney function, tumor size and location, and how well blood pressure was controlled beforehand all shift the odds. The useful question is not “Is it risky?” but “Which of these risks applies most to me, and what are you doing about it?” A team that answers specifically is a team that has thought it through.

Pheochromocytoma surgery recovery time: what the first days and weeks usually look like

The first night is spent somewhere with close monitoring, often a high-dependency or intensive care unit, not because something has gone wrong but because the two predictable problems, low blood pressure and low blood sugar, show up in those hours. Expect frequent blood pressure checks and finger-prick glucose tests. Intravenous fluids usually continue overnight. Many people are surprised to feel tired and foggy rather than relieved; that is the body recalibrating after months of hormone excess.

Hospital stays vary with the approach. Keyhole surgery generally allows discharge within a few days once you are eating, walking and your pressure is stable without intravenous support; open surgery takes longer. Your team will give you their typical range, and it is reasonable to ask what would extend it.

The medicine picture changes quickly. Alpha- and beta-blockers are usually stopped by the team after surgery, since their reason for being has gone. Some people whose blood pressure was high before the tumor still need treatment afterward; others find their readings settle over weeks. Do not adjust anything yourself; the prescriber will set a review date.

At home, the usual advice applies: walk daily, avoid heavy lifting until cleared, keep incisions clean and dry, and watch for the warning signs listed in the final section. Fatigue can persist for a few weeks. If both adrenal glands were removed, you will leave with steroid replacement, a steroid emergency card and sick-day instructions; learning those rules is part of recovery.

Follow-up is where this condition differs from most. The guideline recommends repeating metanephrine testing in the weeks after surgery to confirm the hormone source is gone, then lifelong annual biochemical checks, since recurrence or a second tumor can appear years later. Ask for the schedule in writing before you leave.

What are the 5 P's of pheochromocytoma, and why they matter for your workup

Clinicians remember this tumor with a cluster of P’s: pressure (high blood pressure), pain (headache), perspiration (sweating), palpitations (a racing or pounding heart) and pallor (a pale, clammy appearance during an episode). Some versions add a sixth, paroxysms, because the hallmark is that symptoms come in sudden spells rather than constantly. The classic triad clinicians look for, as described in NHS and other mainstream guidance, is headache, sweating and palpitations occurring together.

This mnemonic is a teaching aid for diagnosis, not a self-test. Each symptom is common and far more often caused by something else, which is exactly why the tumor is rare and why its diagnosis rests on laboratory confirmation rather than a symptom list.

Where the P’s become useful to you is in the pre-operative conversation. The pattern of your episodes tells the anesthesiologist how reactive your tumor is. Someone whose spells are triggered by bending or pressure on the abdomen is flagging a tumor that may release hormone readily when handled. Someone with sustained rather than episodic hypertension may have a tumor producing noradrenaline steadily, which affects how the alpha-blocker is managed. Episodes of pallor and faintness that alternate with hypertension can hint at a tumor also producing adrenaline, with implications for heart-rate control.

Describe your episodes concretely: what starts them, how long they last, what the blood pressure reads if you have measured it, and what you have noticed afterward. Mention any unexplained weight loss, new diabetes or anxiety that felt physical rather than psychological; these are part of the same picture.

Keep a short diary during the preparation period, noting spells and readings. It is the most useful thing you can bring to the pre-op assessment, and it costs nothing but attention.

What people often get wrong about pheochromocytoma surgery

Myths cluster around rare conditions because few people have a friend who has been through it. These are the ones worth correcting before your consultation.

“It is a tumor, so it should come out as fast as possible.” For this tumor, speed without preparation is the danger. The 7-to-14-day run-up in the guideline exists because unprepared patients fare worse. A date two or three weeks away is the safe plan, not a delay.

“My blood pressure is fine, so I do not need the medicines.” Some pheochromocytomas cause only episodic hypertension, and some patients have normal readings in clinic. The guideline recommends preparation for hormone-producing tumors regardless, because handling during surgery can provoke a surge even in someone with no history of spikes.

“Dizziness on the medicine means it is wrong for me.” Lightheadedness on standing is an expected sign that alpha blockade is working and that you need more salt and fluid. Report it; do not stop the medicine.

“Keyhole surgery is minor surgery.” The incisions are small. The physiology is not. The monitoring and the medicines are the same whether the route is laparoscopic or open.

“Once the tumor is out, it is over.” Removing the tumor usually resolves the hormone excess, and many people’s blood pressure improves. But recurrence, a second tumor, and metastatic spread can appear years later, which is why the guideline recommends annual lifelong follow-up. The operation ends one chapter and starts a quieter one.

“Genetic testing is only for young people or those with family history.” Because about one in three patients carries a germline mutation, including many with no family history, current guidance recommends offering testing to everyone with this diagnosis.

“The pathology report will say whether it was cancer.” It will describe features. Malignancy in this tumor is defined by spread, which only time and imaging can reveal.

Questions to ask your care team before pheochromocytoma surgery

Bring these on paper. A good team will welcome them, and the answers will tell you a great deal about how carefully your case has been planned.

About the diagnosis

• Which tests confirmed the tumor is producing hormone, and were any medicines I take able to affect those results?
• Have you looked for tumors elsewhere, including the other adrenal gland?

About genetics

• Will I have germline genetic testing, and which genes are you testing?
• If a mutation is found, how would that change the operation or the follow-up?
• Should my relatives be tested, and who will counsel them?

About timing and preparation

• Which class of blood pressure medicine are you starting first, and why in that order?
• What home readings tell you I am ready, and what readings should make me call you?
• How much extra salt and fluid should I take, and are there reasons that advice might differ for me?
• Which of my current medicines and supplements should pause, and who decides?

About the operation

• Which approach are you planning, and what would make you switch to open surgery?
• Will you remove the whole gland or spare part of it?
• How often does your team operate on this tumor, and how is the anesthesia team involved in planning?
• Where will I be monitored afterward, and for how long?

About afterward

• Which medicines stop after surgery and which continue?
• Will I need steroid replacement, even temporarily?
• When is the first hormone test after surgery, and what does lifelong follow-up look like?
• Who is my point of contact if I have a problem at home?

You do not need every answer in one visit. You do need to know who holds each decision, and that it is held deliberately.

When to call your doctor: red-flag signs before and after surgery

Most of the preparation period and recovery is uneventful. A few situations need a same-day call to your team, and a few need emergency care without waiting for a call back.

Seek emergency care immediately if you have:

• a severe, sudden headache, especially with confusion, weakness on one side, slurred speech or a seizure;
• chest pain, pressure or tightness, or severe shortness of breath;
• a home blood pressure reading far above the threshold your team gave you together with symptoms such as headache, blurred vision or palpitations;
• fainting, or near-fainting that does not resolve on lying down;
• after surgery, heavy bleeding from a wound, a rigid or rapidly swelling abdomen, or signs of shock such as cold clammy skin and a racing pulse;
• after removal of both adrenal glands, vomiting that stops you keeping replacement tablets down, or sudden severe weakness, which can signal an adrenal crisis.

Call your team the same day if you notice:

• persistent dizziness on standing that does not improve with fluids and rest, or a fall;
• readings consistently outside the range you were given, in either direction;
• a fever, redness, warmth or discharge at an incision;
• new calf pain or swelling, which can indicate a clot after surgery;
• shakiness, sweating or confusion that improves with eating, which may be low blood sugar in the early days;
• a return of your old spells of headache, sweating and palpitations at any point after surgery, even years later.

Keep the team’s direct number and the hospital emergency line where you can find them, and tell whoever is with you what to watch for. If you carry a steroid emergency card, show it to any clinician you meet.

None of this list replaces your own team’s instructions. If they have given you a different threshold or a different number to call, theirs takes precedence.

Frequently asked questions

How should I prepare for pheochromocytoma surgery?

Preparation centers on medicines that block the effects of adrenaline, started by your team roughly one to two weeks beforehand, together with extra salt and fluids to refill expanded blood vessels. You will take home blood pressure readings sitting and standing, avoid activities and products that trigger hormone surges, and bring a full medicine and supplement list to your pre-op visit. Your prescriber adjusts the plan; do not change anything yourself.

What is the 10% rule for pheochromocytoma?

The rule of tens is an older teaching mnemonic: about 10% bilateral, 10% outside the adrenal gland, 10% malignant, 10% familial and 10% in children. Genetic sequencing has overturned the familial figure; current guidelines report that roughly a third of patients carry an inherited mutation, so testing is now recommended for everyone with the diagnosis rather than only those with a family history.

What are the 5 P's of pheochromocytoma?

Clinicians summarize the condition as pressure, pain (headache), perspiration, palpitations and pallor, often adding paroxysms because symptoms come in sudden spells. It is a memory aid for doctors, not a self-diagnosis tool, since each symptom is common and usually caused by something else. The pattern of your episodes does help your anesthesia team judge how reactive the tumor may be during surgery.

How risky is pheochromocytoma surgery?

It is major surgery with specific hazards: blood pressure surges when the tumor is handled, sharp drops once its vein is clipped, heart rhythm disturbances, bleeding, and low blood sugar afterward. Guideline authors note that serious complications have become uncommon with modern preparation and anesthesia, but risk depends on your heart and kidney health, tumor size and how well blood pressure was controlled beforehand. Ask which risks apply most to you.

How long does alpha blockade before pheochromocytoma surgery take?

The Endocrine Society guideline suggests starting an alpha-blocker roughly 7 to 14 days before the operation, with the medicine adjusted upward over that period according to your blood pressure readings. Some people with severe hypertension or heart strain need longer. The goal is controlled blood pressure, a filled circulation and a stable heart rate, which your team confirms before setting the final date.

Is pheochromocytoma genetic testing necessary before surgery?

Guidelines recommend offering germline testing to all patients, because about one in three carries an inherited mutation, often without any family history. The result can change the operation, for instance by favoring a gland-sparing technique in syndromes that cause bilateral tumors, and it shapes lifelong follow-up and whether relatives should be screened. The sample is usually taken before surgery even if results arrive afterward.

What is pheochromocytoma surgery recovery time?

Recovery depends on the approach. After keyhole surgery, people are usually home within a few days once eating, walking and keeping stable blood pressure without intravenous support; open surgery takes longer. Fatigue can last a few weeks. Hormone testing follows in the weeks after surgery to confirm the source is gone, and annual checks continue for life. Ask your team for their typical range.

Why do I need to eat extra salt before pheochromocytoma surgery?

Months of excess adrenaline keep blood vessels narrowed, and your circulating blood volume shrinks to match. When the alpha-blocker opens those vessels, there is not enough fluid to fill them, which causes dizziness on standing and makes blood pressure drops during surgery more severe. Extra sodium and fluid, sometimes with intravenous saline before the operation, restore the volume. Your team will tailor this if you have heart or kidney disease.

Can a pheochromocytoma be managed without surgery?

Surgery is the standard treatment for a hormone-producing tumor because medicines control the effects but not the source. Long-term alpha blockade is used when surgery is unsafe, such as with severe other illness, or when disease has already spread widely, where targeted radiotherapy or systemic treatments may be discussed instead. That judgment belongs to your endocrine and surgical team based on your overall health and imaging.

Will I need steroid tablets after pheochromocytoma surgery?

Only if you lose enough adrenal cortex to leave you unable to make cortisol, which happens when both glands are fully removed or when the remaining gland was already removed or damaged. Removing one gland with a healthy gland on the other side usually does not require replacement. Cortical-sparing surgery in hereditary bilateral disease aims to preserve enough tissue to avoid it. Your team will confirm the plan before discharge.

References

• Phaeochromocytoma (NHS)
• Pheochromocytoma (MedlinePlus Medical Encyclopedia)

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.